Clinical Trials

Showing trials with last updates posted in 2026.

NCT05512390 | ACTIVE_NOT_RECRUITING | PHASE1
39 participants

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2023-04-26
Completion:
2027-02-28
Conditions
  • Diffuse Large B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Follicular Lymphoma
Interventions
  • DRUG
No Results Yet
NCT05455320 | ACTIVE_NOT_RECRUITING | PHASE3
864 participants
NCT05438043 | ACTIVE_NOT_RECRUITING | PHASE3
213 participants

A Study of Daratumumab

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2022-12-15
Completion:
2029-01-31
Conditions
  • Multiple Myeloma
Interventions
  • DRUG
No Results Yet
NCT05416255 | COMPLETED | NA
80 participants

Measuring Synovial Fluid Components

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2022-04-19
Completion:
2026-04-20
Conditions
  • Knee Osteoarthritis
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page